Research

My research focus on understanding how the environment impacts human development and adult homeostasis. I am doing this by using clinical studies in combination with animal models, cellular assays, and modelling. The central aims of this work have been in a translational manner to understand disease mechanisms and create better treatment for patients by: (i) identifying new drug targets; (ii) understanding side effects of drugs already in the clinic; and (iii) understanding how ubiquitous xenobiotics can drive recent increases in prevalence of adverse health outcomes within reproduction, metabolism, and neurobiology. My studies have led to work at Massachusetts General Hospital (Boston, USA), Mont Sinai Hospital (NYC, USA), and Inserm (Rennes, France). I am affiliated as Senior Scientist to Inserm.

Management and Cooperation

2011-2014       Postdoc fellow, Inserm Unit 1085, Université de Rennes I, France/Department of Biomedical Sciences, Faculty of Health and Medical Sciences, UCPH.

2014-2016      Assistant Professor, Laboratory of Genomics and Molecular Biomedicine, Department of Biology, Faculty of Science, UCPH.

2016-2017      Assistant Professor, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, UCPH,

2017-2021       Head of Translational Research Unit/Associate Professor, Rigshospitalet and University of Copenhagen/Senior Researcher, INSERM UMR 1085, Université de Rennes 1, France.

2021-2022      Principal Clinical Pharmacology Scientist, Obesity and NASH, Novo Nordisk, Søborg, Denmark.

2022-                Professor of Molecular Physiology, Department of Science and Environment, Roskilde University/Senior Researcher, INSERM UMR 1085, Université de Rennes 1, France/Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet.